Linde India Ltd
Linde India Ltd Q1 FY25 Results & Presentation Highlights: Revenue, Margins & Order Book
Q1 FY25 investor presentation: what the company reported on revenue, margins and projects.
Based on Linde India Ltd's Q1 FY25 investor presentation. The company has not published an earnings-call transcript for this quarter, so figures here are what the presentation reports, not management guidance.
The short version
Revenue for year ended Mar 2024: ₹27,687 million, down 12% vs. EBITDA: For year ended March 2024, EBITDA was INR 7,793 million, down 11% from INR 8,736 million for the 15-month period ended March 2023 (Page 9 and 8).
From Linde India Ltd's Q1 FY25 earnings-call transcript · updated 24 Sept 2026.
Revenue & Sales Performance
- Revenue for year ended Mar 2024: ₹27,687 million, down 12% vs. 15-month ended Mar 2023 (₹31,355 million).
- When compared on a similar 12-month basis, revenue grew 6.4% YoY.
- Gases division revenue grew 10.2% YoY (+₹1,840 million), driven by high gas & liquid demand and pricing discipline.
- Project Engineering Division (PED) revenue declined marginally by 2.2% YoY (-₹166 million) due to project billing cycles.
- EBITDA declined 11% YoY but showed a 7.2% increase when compared on a similar 12-month basis.
- Cash generation from operations: ~₹5,900 million, with cash balance ~₹9,700 million at year-end.
2 more points management made on revenue & sales performance
Profitability & Margins
See what Linde India Ltd said on profitability & margins — free account, 30 seconds.
Capital Expenditure Plans
- Healthy Order book of ~20 billion INR as of March 2024 (Page 5).
- Focus on expanding manufacturing and project capabilities in high-growth markets and segments such as metallurgy (steel, stainless steel), chemistry (pharma, chemicals), food & beverage (N2 dosing, cryo-grinding), healthcare (PSA, MGPS), electronics (semiconductors, PV solar), and primary metals (steel, copper, aluminium) (Page 12).
- Ongoing digitalization projects including Production Planning tools (iPlan, MPC+), Engineering Design Assist (PED), and eRFQ for vendor selection, some marked as "Work in Progress" (Page 14).
- No specific capex amounts, new plant locations, or exact timelines for capacity expansion or new projects explicitly stated in the presentation.
2 more points management made on capital expenditure plans
Top-ranked in Chemicals & Petrochemicals
Ranked on what management guided this quarter
Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.
Fundraising & Capital Structure
See what Linde India Ltd said on fundraising & capital structure — free account, 30 seconds.
Order Book & Pipeline
- The presentation reports a healthy order book position of approximately ₹20 billion as of March 2024 (Page 5).
- It highlights the Project Engineering Division (PED) having a strong and resilient focus to win projects across diverse industries despite a marginal revenue decline (Page 5).
- No specific order inflow or pending orders figures are mentioned beyond the order book in the presentation.
Linde India Ltd — Quarterly revenue & net profit
Reported quarterly figures (₹ Cr). Latest: revenue ₹701 Cr, net profit ₹192 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.
Full financials →Continue your research
What Linde India Ltd's management said in earlier quarters
Others in Chemicals & Petrochemicals this season
- Himadri Speciality Chemical Ltd (Q1 FY25)
1,199.77 Cr, up 26.17% YoY (vs Rs. Key investor presentation takeaways from Himadri Speciality Chemical Ltd's Q1 FY25 investor presentation — and how it ranks a
- Balaji Amines Ltd (Q1 FY25)
Q1FY25 consolidated revenue from operations: ₹393 crore, down 16% YoY from ₹469 crore in Q1FY24 (Page 5 & 6). Key investor presentation takeaways from Balaji Am
- Vidhi Specialty Food Ingredients Ltd (Q1 FY25)
83.0 Crs, up 4.1% year-on-year from Rs. Key investor presentation takeaways from Vidhi Specialty Food Ingredients Ltd's Q1 FY25 investor presentation — and how
- GOCL Corporation Ltd (Q1 FY25)
Consolidated revenue for FY 2023-24: INR 949 crores, down from INR 1409.71 crores in FY 2022-23. Key investor presentation takeaways from GOCL Corporation Ltd's
Frequently Asked Questions
What were Linde India Ltd Q1 FY25 results?
Revenue for year ended Mar 2024: ₹27,687 million, down 12% vs. EBITDA: For year ended March 2024, EBITDA was INR 7,793 million, down 11% from INR 8,736 million for the 15-month period ended March 2023 (Page 9 and 8).
What is Linde India Ltd share price analysis?
Linde India Ltd currently shows a neutral. The stock trades at a P/E of 97.0 with a market cap of ₹53,228 Cr. Investors should review the full earnings analysis for detailed insights.
Is Linde India Ltd planning capital expenditure?
Healthy Order book of ~20 billion INR as of March 2024 (Page 5).
Keep Linde India Ltd on your radar — track it to get its next earnings analysis in your feed.
This analysis is AI-generated based on publicly available earnings data and the company's investor presentation. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.